{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-21-115812","form_type":"8-K","ticker":"NXGL","cik":"0001468929","company_name":"NEXGEL, INC.","filed_at":"2021-09-15T23:59:59+00:00","discovered_at":"2026-05-14T18:04:18.187789+00:00","generated_at":"2026-06-29T03:29:40.248919+00:00","sec_items":["5.02","8.01","9.01"],"event_type":"leadership","sentiment":"positive","materiality_score":0.35,"calibrated_materiality_score":0.35,"confidence":"high","headline":"NEXGEL appoints three directors, grants options to purchase 1.5M shares at $0.15 each","bullets":["Yaakov Spinrad, Miranda Toledano, and CEO Adam Levy appointed to Board.","Each appointee received a non-qualified option for 500,000 shares at $0.15, vesting in four quarterly installments starting Oct 1, 2021.","Toledano expected to chair future Audit Committee; eligible for $10,000 quarterly retainer upon national exchange listing.","Toledano brings over 20 years biopharma and capital markets experience, including roles at TRIGR, Sorrento, and Royalty Pharma."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-21-115812","json":"https://secwatch.observer/filing/0001104659-21-115812.json","markdown":"https://secwatch.observer/filing/0001104659-21-115812.md","text":"https://secwatch.observer/filing/0001104659-21-115812.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1468929/000110465921115812/0001104659-21-115812-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1468929/000110465921115812/tm2127717d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-29T03:29:40.248919+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"161b801347","claim":"Yaakov Spinrad was appointed as Director at NEXGEL, INC..","evidence_excerpt":"On September 9, 2021, Yaakov Spinrad, Miranda J. Toledano and Adam Levy (the “ Board Appointees ”) were appointed to the board of directors","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1468929/000110465921115812/0001104659-21-115812-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"7422127f0f","claim":"Miranda J. Toledano was appointed as Director at NEXGEL, INC..","evidence_excerpt":"On September 9, 2021, Yaakov Spinrad, Miranda J. Toledano and Adam Levy (the “ Board Appointees ”) were appointed to the board of directors","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1468929/000110465921115812/0001104659-21-115812-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"92cb27aa2c","claim":"Adam Levy was appointed as Director at NEXGEL, INC..","evidence_excerpt":"On September 9, 2021, Yaakov Spinrad, Miranda J. Toledano and Adam Levy (the “ Board Appointees ”) were appointed to the board of directors","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1468929/000110465921115812/0001104659-21-115812-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}